Comparative effect of Myofascual release technique and lifestyle modification in prehypertension individuals ARANDOMIZED CONTROLLED TRIA
Phase 2
Completed
- Conditions
- Health Condition 1: I10- Essential (primary) hypertension
- Registration Number
- CTRI/2024/01/061395
- Lead Sponsor
- KLE Academy of higher education and research
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 32
Inclusion Criteria
age between 35 to 65
-BMI 23 to 36kg per meter square
-Perceived stress scale
-International physical activity questionnaire
- Willingness to participate
Exclusion Criteria
partcipants with comorbidities
DVT
Diagnosed with hypotension, stage I or II hypertension
pregnant and lactating women
Those who have had episodes of transient hypertension in last 6
month.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Mercury sphygmomanometer: Blood pressure will be assessed at baseline, after 4 weeks and at a 1 month of follow up.Timepoint: Blood pressure will be assessed at baseline, after 4 weeks and at a 1 month of follow up.
- Secondary Outcome Measures
Name Time Method Pulse Oximetry to measure SpO2 <br/ ><br>International physical activity questionnaire <br/ ><br>Ankle – Brachial Index <br/ ><br>Timepoint: Pulse rate, sp02 & ankle brachial index will be assessed at baseline, after 4 weeks & at a 1 month of follow up.